Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thorsten, Radolf"'
Autor:
Berthold A. Nock, Oleg G. Chepurny, Panagiotis Kanellopoulos, Aikaterini Kaloudi, Thorsten Radolf, George G. Holz, Fritz Andreae, Maritina Rouchota, George Loudos, Theodosia Maina
Publikováno v:
Mol Pharm
Radiolabeled gastrin analogues have been proposed for theranostics of cholecystokinin subtype 2 receptor (CCK(2)R)-positive cancer. Peptide radioligands based on other receptor antagonists have displayed superior pharmacokinetics and higher biosafety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704d032796bfefaa5241e4c7a6c1b705
https://europepmc.org/articles/PMC7429258/
https://europepmc.org/articles/PMC7429258/
Autor:
Aikaterini Kaloudi, Panagiotis Kanellopoulos, Thorsten Radolf, Chepurny, Oleg G., Rouchota, Maritina, Loudos, George, Andreae, Fritz, Holz, George G., Nock, Berthold Artur, Maina, Theodosia
Publikováno v:
Molecular Pharmaceutics; 8/3/2020, Vol. 17 Issue 8, p3116-3128, 13p
Autor:
Anna Helbok, Christine Rangger, Fritz Andreae, Elisabeth von Guggenberg, Matthias Saba-Lepek, Thorsten Radolf, Gudrun C. Thurner, Ruth Prassl, Clemens Decristoforo
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 8:112-118
Radiolabeled PEGylated liposomal nanoparticles (NPs) open new possibilities for a variety of applications including diagnosis, drug delivery, targeted therapy, and monitoring treatment effects. Here we describe the characterization of liposomal NPs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0055393e7934f56ceb9dd04f2806888d
https://doi.org/10.1016/j.nano.2011.04.012
https://doi.org/10.1016/j.nano.2011.04.012
Autor:
Christine, Rangger, Anna, Helbok, Meltem, Ocak, Thorsten, Radolf, Fritz, Andreae, Irene J, Virgolini, Elisabeth, Von Guggenberg, Clemens, Decristoforo
Publikováno v:
Anticancer research. 33(4)
Vasoactive intestinal peptide (VIP) receptors are overexpressed in a broad variety of tumours. For the detection of these tumours, novel chemically modified and shortened VIP derivatives were designed.1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1802bf27b6f3b6373aa8f12e777c6fd7
https://pubmed.ncbi.nlm.nih.gov/23564795
https://pubmed.ncbi.nlm.nih.gov/23564795